The total return over the past 12 months is +18.13% vs. +16.94% for the S&P 500. So far it's up -21.06% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +18.13% | +17.82% | (0.38%) | N/A | N/A | N/A |
| Total Return CAGR | +18.13% | +17.82% | (0.38%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Dyne Therapeutics, Inc. (DYN)
| Year | Start price | End price | DYN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $19.56 | $15.44 | (21.06%) | +14.51% | (35.57%) |
| 2025 | $23.56 | $19.56 | (16.98%) | +17.72% | (34.70%) |
| 2024 | $13.30 | $23.56 | +77.14% | +24.89% | +52.25% |
| 2023 | $11.59 | $13.30 | +14.75% | +26.19% | (11.44%) |
| 2022 | $11.89 | $11.59 | (2.52%) | (18.17%) | +15.65% |
| 2021 | $21.00 | $11.89 | (43.38%) | +28.74% | (72.12%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
